CoChat

Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial

Open access

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: This study investigated the effects of a marine oil extract (PCSO-524®) on inattention, hyperactivity, mood and cognition in children and adolescents. PCSO-524® is a standardised lipid extract of the New Zealand green-lipped mussel and is an inflammatory modulator that inhibits the 5'-lipoxygenase and cyclooxygenase pathways and decreases concentrations of the pro-inflammatory arachidonic acid (AA). METHODS: PCSO-524® or a matched placebo was administered for 14 weeks to 144 participants (123 males/21 females; mean age 8.7 years) with high hyperactivity and inattention in a randomised, double-blind, placebo-controlled study. The primary outcome was the Conners Parent Rating Scale assessing parental reports of behavioural problems. Secondary outcomes assessed changes in cognition and mood. RESULTS: The results of the present study did not support the hypothesis that PCSO-524® improves parental reports of hyperactivity, inattention and impulsivity in children ages 6 to 14 years over placebo. Repeated measures ANOVA on post hoc subsample analysis indicated significant improvements in hyperactivity (p = 0.04), attention (p = 0.02), learning (p = 0.05) and probability of ADHD (p = 0.04) with a medium to large average effect size (d = 0.65) in those children who did not meet criteria for combined hyperactivity and inattention. Furthermore, significant improvements in the PCSO-524® group were indicated in a whole sample repeated measures ANCOVA on recognition memory between baseline and week 8 over placebo (p = 0.02, d = 0.56); this difference was not sustained at week 14. CONCLUSIONS: The results presented indicate that PCSO-524® may be beneficial in reducing levels of hyperactivity and inattention in a population of children with clinical and subclinical symptoms of ADHD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00213-016-4471-y

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flowchart of study protocol
Fig. 1 Flowchart of study protocolCC BY · PubMed Central
Fig. 2 Graphs showing accuracy percentage on picture recognition accuracy, accuracy for correct target picture recognition and accuracy for correct non-target picture recognition
Fig. 2 Graphs showing accuracy percentage on picture recognition accuracy, accuracy for correct target picture recognition and accuracy for correct non-target picture recognitionCC BY · PubMed Central
Fig. 3 Effects of PCSO-524® (Lyprinol/Omega-XL) on the numeric working memory outcomes. Graphs depict mean COMPASS reaction time scores with SD at baseline, week 8 and week 14 compared to placebo. Significant differences (*p < 0.05) are indicated; Cohen’s d effect sizes are provided
Fig. 3 Effects of PCSO-524® (Lyprinol/Omega-XL) on the numeric working memory outcomes. Graphs depict mean COMPASS reaction time scores with SD at baseline, week 8 and week 14 compared to placebo. Significant differences (*p < 0.05) are indicated; Cohen’s d effect sizes are providedCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Cited by

See all 32

Metadata

Authors
Kean, J. D., Sarris, J., Scholey, A., Silberstein, R., Downey, L. A., & Stough, C.
Affiliations
  • Swinburne University of Technology (AU)
  • The University of Melbourne (AU)
Corresponding author
Stough, Con
Venue
Psychopharmacology
Published
2016-12-05
Volume
234
Issue
3
Pages
403-420
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2560670432
Cited by
32
References
61
Citations by year
2026: 3 · 2025: 2 · 2024: 7 · 2023: 3 · 2022: 1 · 2021: 6 · 2020: 4 · 2019: 1 · 2018: 2 · 2017: 3
FWCI
1.78
Type
journal article
Language
en
Open access
Locations
  • Psychopharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Figshare (submittedVersion, cc-by)
  • Swinburne figshare (Swinburne University of Technology) (submittedVersion, cc-by)
  • Swinburne figshare (Swinburne University of Technology) (cc-by)
Funders
Pharmalink
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
Keywords
attention deficit hyperactivity disorder, hyperactivity, inattention, children and adolescents, green-lipped mussel, lipid extracts, 5-lipoxygenase inhibition, cyclooxygenase inhibition, arachidonic acid, inflammation, cognition, recognition memory, mood, dietary supplementation
MeSH terms
Olive Oil, Adolescent, Affect, Attention, Attention Deficit Disorder with Hyperactivity, Child, Cognition, Double-Blind Method, Female, Humans, Lipids, Male, Vitamin E, Vitamins, Fatty Acids, Omega-3, Treatment Outcome, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial. https://app.cochat.ai/papers/10.1007/s00213-016-4471-y
The paper
Kean, J. D., Sarris, J., Scholey, A., Silberstein, R., Downey, L. A., & Stough, C. (2017). Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial. Psychopharmacology. https://doi.org/10.1007/s00213-016-4471-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.